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It has been suggested that a generalized coronary vasomotion 
disorder is present in variant angina and that evaluation of 
baseline coronary artery tone may be useful for predicting the 
occurrence of coronary artery spasm. The vasomotor response of 
angiographically normal proximal and distal coronary artery 
segments was studied in 9 patients with atypical chest pain and 
normal coronary arteriograms (control group), 13 patients with 
active variant angina and 41 patients with chronic stable angina. 
Ergonovine (intravenous, 100 to 300 ILg, or intracoronary, 8 to 
20 /Lg, was administered to all 22 patients in the control and 
variant angina groups and to 11 of the 41 patients with chronic 
stable angina. All patients also received intracoronary isosorbide 
dinitrate (1 to 2 mg). 
Computerized coronary artery diameter measurement of an-
giographically normal segments was carried out before and after 
ergonovine and nitrate administration. Mean baseline intralumi-
nal diameter of proximal and distal coronary segments was not 
significantly different in control patients and those with variant 
angina (nonspastic segments only) or coronary artery disease 
Recently, Hoshio et al. (l) reported that in patients with 
vasospastic angina, a coronary vasomotion disorder that 
involves increased basal coronary artery tone and hypersen-
sitivity to vasoconstrictive stimuli is present not only at a 
localized segment, but also in the entire coronary artery tree. 
Such findings, however, have not been reported in western 
patients. These authors (1) also suggested that evaluation of 
basal coronary artery tone could be useful for predicting the 
occurrence and location of coronary artery spasm. 
We used quantitative coronary arteriography to assess 
prospectively whether the magnitude of baseline coronary 
artery diameter and the vasomotor response of angiograph-
ically normal epicardial coronary artery segments (nonspas-
tic segments only in those with variant angina) differ in 
Caucasian patients with variant angina, chronic stable an-
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(proximal 2.89 ± 0.15, 2.83 ± 0.14 and 2.82 ± 0.09 mmj distal 
1.60 ± 0.08, 1.63 ± 0.07 and 1.62 ± 0.06 mm, respectively). After 
ergonovine, proximal segments constricted by 10 ± 2%, 15 ± 3% 
and 11 ± 4% and distal segments by 11 ± 3%, 11 ± 2% and 
14 ± 3% in control, variant angina and coronary artery disease 
groups, respectively (p = NS). After isosorbide dinitrate, proxi-
mal coronary segments dilated by 13 ± 2%,11 ± 3% and 8 ± 2% 
(p = NS) and distal segments by 13 ± 3%,14 ± 4% and 15 ± 2% 
(p = NS) in control, variant angina and coronary artery disease 
groups, respectively. 
The results of this study indicate that rest baseline coronary 
tone and the vasomotor response of angiographically normal 
coronary artery segments to ergonovine and isosorbide dinitrate 
are similar in patients with noncardiac chest pain, Prinzmetal's 
variant angina and coronary artery disease. Evaluation of basal 
coronary artery diameter, therefore, is not useful for predicting 
the occurrence or location of coronary spasm. 
(J Am Coll CardioI1991;17:1058-62) 
gina or atypical chest pain but normal coronary arterio-
grams. 
Methods 
Study patients. The study group comprised 63 patients; 9 
had atypical chest pain and normal coronary arteriograms 
(control group), 13 had Prinzmetal's variant angina and 41 
had chronic stable angina. 
Control group. Six women and three men, aged 46 to 67 
years (mean 54 ± 7), were studied. These patients had 
atypical chest pain, a negative exercise test and angiograph-
ically normal coronary arteries. All had been referred for 
coronary arteriography by their treating physician. None of 
these patients had left ventricular hypertrophy, systemic 
hypertension, coronary artery spasm, cardiomyopathy, val-
vular heart disease or conduction disturbances. In all cases, 
chest pain was most probably noncardiac in origin. 
Prinzmetal's variant angina. The 13 patients with vaso-
spastic angina (10 men and 3 women, aged 37 to 65 years 
[mean 50 ± 7]) were studied while in an active phase of their 
disease. Six had significant coronary artery stenosis and the 
0735-1097/9\/$3.50 
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Table 1. Coronary Artery Diameter on Baseline Arteriograms, Control Arteriograms Before Ergonovine and Control Arteriograms Before 
Isosorbide Dinitrate (ISDN) in 63 Patients 
Proximal Segments (mm) Distal Segments (mm) 
Control Control Control Control 
Baseline Ergonovine ISDN Baseline Ergonovine ISDN 
Control group 2.89 ± 0.15 2.94 ± 0.13 2.75 ± 0.09 1.60 ± 0.08 1.58 ± 0.07 1.56 ± 0.07 
(n = 9) 
Variant angina* 2.83 ± 0.14 2.83 ± 0.14 2.83 ± 0.14 1.63 ± 0.07 1.63 ± 0.07 1.63 ± 0.07 
(n = 13) 
Coronary artery disease 2.82 ± 0.09 2.85 ± 0.08 2.76 ± 0.09 1.62 ± 0.06 1.60 ± 0.05 1.56 ± 0.05 
(n = 41) 
*Only measurements at baseline arteriography were used as control data to assess diameter changes with ergonovine and nitrate. 
remaining seven had angiographically normal coronary ar-
teries, Ergonovine or hyperventilation tests carried out 48 to 
72 h before cardiac catheterization provoked angina and ST 
segment elevation in all patients. During coronary arteriog-
raphy, intracoronary (8 to 20 p,g, four patients) or intrave-
nous (l00 to 300 p,g, nine patients) ergonovine provoked 
focal occlusive or subocclusive coronary artery spasm in all 
patients. 
Coronary artery disease. Forty-one patients (31 men and 
10 women, aged 38 to 70 years [mean 54 ± 12]), with chronic 
stable exertional angina, a positive exercise test and angio-
graphically documented coronary artery disease (~50% 
fixed reduction in intraluminal diameter of at least one major 
coronary artery) were studied. Nine patients had single 
vessel, 20 had double vessel and 12 had triple vessel disease. 
Five patients had suffered a myocardial infarction 1 to 3 
years before study entry. 
Study protocol. Written informed consent was obtained 
from every patient before study entry. The study protocol 
was approved by the Ethics Committee of Hammersmith 
Hospital. 
Coronary arteriography. All antianginal medication was 
discontinued before the study, with the exception of sublin-
gual nitrates, which were allowed for relief of anginal at-
tacks. All patients were fasting and had not smoked or 
received acute nitrates for ~4 h before cardiac catheteriza-
tion. After diagnostic coronary arteriography, orthogonal 
views of angiographically normal coronary segments were 
obtained before the administration of ergonovine or isosor-
bide dinitrate (baseline control arteriograms). Arteriograms 
of the relevant coronary segments were repeated 2 to 4 min 
after ergonovine. A second control coronary arteriogram 
was obtained 5 to 7 min after ergonovine, and isosorbide 
dinitrate was given immediately thereafter. Arteriograms of 
the relevant coronary segments were repeated 2 to 4 min 
after the administration of isosorbide dinitrate. 
Control group. Ergonovine, which was given to all pa-
tients in this group (intracoronary, 20 p,g, in two and 
intravenous, 300 p,g, in seven), did not provoke angina or ST 
segment shifts. Intracoronary isosorbide dinitrate (l mg) was 
given to all nine patients 5 to 7 min after ergonovine 
(preceded by a control angiogram). Coronary arteriograms 
were repeated 2 to 4 min after ergonovine and isosorbide 
dinitrate. 
Prinzmetal's variant angina. Ergonovine was adminis-
tered to all 13 patients (intracoronary, 8 to 20 p,g, in 4 
patients and intravenously, 100 to 300 p,g, in 9). In all 
patients, focal spasm developed, which was promptly re-
lieved with 1 to 2 mg of intracoronary isosorbide dinitrate. 
Coronary arteriograms were repeated during ergonovine-
induced spasm and 2 to 4 min after isosorbide dinitrate. 
Because of the prompt administration of isosorbide dinitrate, 
control arteriograms were not obtained after ergonovine in 
these patients and baseline coronary diameters were used as 
control measurements. For the purpose of the study, only 
angiographically normal nonspastic segments were ana-
lyzed. 
Coronary artery disease. Ergonovine was given to 11 of 
the 41 patients (intracoronary, 20 p,g, in 6 and intravenous, 
300 p,g, in 5). Angina and ST segment depression developed 
after ergonovine in two patients and was associated 
with mild diffuse coronary artery constriction (but not 
focal coronary spasm). This was rapidly relieved by 
intracoronary isosorbide dinitrate (2 mg). Intracoronary 
isosorbide dinitrate (1 to 2 mg) was administered to all 
patients, in 30 as the only vasoactive stimulus and in the 
remaining 11 after ergonovine (preceded by a control coro-
nary arteriogram). 
Measurement of coronary artery diameter. Our technique 
for measuring coronary artery diameter has been reported in 
detail previously (2). Briefly, coronary luminal diameter was 
measured by an automated edge contour detection system 
(Coronary Angiography Analysis System [CAAS], Pie Data 
Medical). The stem of the Judkins coronary catheter was 
used for calibration to determine absolute measurement in 
millimeters and correction was made for radiographic pin-
cushion distortion. Arteriograms were analyzed by two 
independent observers and blindly reanalyzed at a remote 
time for reproducibility of the method. 
All major coronary arteries were arbitrarily divided into 
thirds and, for the purpose of the study, only angiographi-
cally normal segments located in proximal (proximal third) 
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Figure 1. Mean baseline coronary artery diameter of angiographi-
cally normal (nonspastic segments in patients with variant angina) 
proximal coronary artery segments and of distal coronary segments 
in the control group, Prinzmetal's variant angina group and coronary 
artery disease (CAD) group. Basal coronary tone appears to be 
similar in the three groups. 
and distal (distal third) locations were analyzed. Spastic 
segments in patients with Prinzmetal's variant angina were 
excluded from analysis. To quantify changes in "coronary 
artery tone" (I), the percent vasoconstriction after er-
gonovine and dilation after isosorbide dinitrate were calcu-
lated as follows: 
Constriction after ergonovine = [(Control diameter 
- Diameter after ergonovine)/Control diameter] x 100 (%). 
Dilation after nitrate = [(Diameter after nitrate 
- Control diameter)/Control diameter] x 100 (%). 
Data analysis. All group data are presented as mean 
values ± SE. Differences between proportions were ana-
lyzed by Yates-corrected chi-square test. Paired and un-
paired Student's t tests were used to analyze continuous 
data. A p value < 0.05 was considered significant. 
Results 
Baseline and control coronary artery diameter (Table 1). 
We analyzed 50 angiographically normal segments in the 9 
control patients, 65 in the I3 patients with vasospastic angina 
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and 82 in the 41 patients with coronary artery disease. Mean 
baseline diameter of proximal and distal coronary segments 
was similar in patients with atypical chest pain (control 
group), Prinzmetal's variant angina and coronary artery 
disease (proximal 2.89 ± 0.15, 2.83 ± 0.14 and 2.82 ± 
0.09 mm; distal 1.60 ± 0.08, 1.63 ± 0.07 and 1.62 ± 0.06 mm, 
respectively) (Fig. I). Baseline coronary diameter of proxi-
mal and distal segments, control diameter preceding er-
gonovine and control diameter preceding isosorbide dinitrate 
were not significantly different in patients with atypical chest 
pain (control group), variant angina and coronary artery 
disease. 
Effects of ergonovine on coronary artery diameter (Table 
2). After ergonovine, all patients with variant angina devel-
oped focal occlusive (10 patients) or subocclusive (3 pa-
tients) coronary artery spasm. On average, spastic segments 
constricted by 78 ± 2% and nonspastic segments by I3 ± 
3%. All 41 patients with coronary artery disease had mild 
diffuse coronary constriction; in 2, angina and ST segment 
depression developed and was associated with 15% and 18% 
diameter reduction, respectively, but coronary occlusion did 
not occur. 
Proximal coronary segments constricted by lO ± 2%, 
15 ± 3% and II ± 4% in the control, variant angina and 
coronary artery disease groups, respectively (p = NS). 
Distal coronary segments in these three patient groups 
constricted by II ± 3%, II ± 2% and 14 ± 3%, respectively 
(p = NS) (Fig. 2). 
Response to intracoronary isosorbide dinitrate (Table 3). 
Vasodilation of proximal coronary segments after isosorbide 
dinitrate was I3 ± 2% in the control group, II ± 3% in the 
Prinzmetal's variant angina group, and 8 ± 2% in the 
coronary artery disease group (p = NS) (Fig. 3). Dilation of 
the distal segments in these three patient groups was I3 ± 
3%, 14 ± 4% and 15 ± 2%, respectively (p = NS). Dilation 
after isosorbide dinitrate was similar in patients who re-
ceived only isosorbide dinitrate and patients in whom it 
was given after ergonovine (proximal segments 8.8 ± 2% 
and 8.2 ± 2%; distal 10.8 ± 3% and 11.4 ± 3%, respectively). 
In patients with coronary artery disease, dilation after 
isorbide dinitrate was significantly larger in distal than 
Table 2. Coronary Artery Diameter of Proximal and Distal Segments on the Control Arteriogram and After Intracoronary or Intravenous 
Ergonovine in 33 Patients 
Proximal Segments Distal Segments 
Control Ergonovine % Control Ergonovine % 
(mm) (mm) Reduction (mm) (mm) Reduction 
Control group 2.94 ± 0.13 2.64 ± 0.14 10 ± 2 1.58 ± 0.7 1.40 ± 0.09 II ± 3 
(n = 9) 
Variant angina 2.83 ± 0.14 2.40 ± 0.16 15 ± 3 1.63 ± 0.07 1.44 ± 0.06 II ± 2 
(n = 13) 
Coronary artery disease 2.85 ± 0.15 2.50 ± 0.15 II :!: 4 1.60 ± 0.09 1.39 ± 0.09 14 ± 3 
(n = II) 
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Figure 2. Coronary artery constriction (percent change in coronary 
diameter compared with control) of angiographically normal (non-
spastic segments in patients with variant angina) proximal and distal 
coronary segments in response to ergonovine. No significant differ-
ences in response to ergonovine were observed in the three patient 
groups. CAD = coronary artery disease. 
proximal segments (8 ± 2% versus 15 ± 2%; p < 0.05) 
(Fig. 3). 
Discussion 
Basal coronary tone in variant angina and coronary artery 
disease. This study demonstrates that basal coronary tone of 
angiographically normal coronary artery segments is not 
significantly different in patients with atypical chest pain, 
those with variant angina and patients with coronary artery 
disease. Furthermore, the response of these coronary seg-
ments (nonspastic segments only in patients with variant 
angina) to ergonovine and isosorbide dinitrate was similar in 
the three groups of patients. 
Our findings do not confirm the observation by Hoshio et 
al. (1) that baseline coronary artery diameter is significantly 
smaller in patients with variant angina than in a control 
group without ischemic heart disease. In our study, baseline 
coronary diameter was similar in patients with active Prinz-
metal's variant angina or chronic stable angina and a control 
group of patients with atypical chest pain who had no 
objective evidence of a cardiac origin for their symptoms. 
Our findings, which are in agreement with previous reports 
from our institution (2,3) and others (4,5), indicate that 
generalized baseline coronary vasoconstriction is not 
present in variant angina. Therefore, evaluation of baseline 
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coronary artery diameter does not appear to be useful for 
predicting the occurrence and location of coronary artery 
spasm . 
In all our patients with variant angina, ergonovine caused 
focal spasm of certain coronary segments but mild and 
diffuse coronary vasoconstriction of nonspastic segments, 
thus confirming previous observations (2-4,6-10) that local 
coronary hyperreactivity is of paramount importance in the 
genesis of coronary spasm in patients with vasospastic 
angina. Coronary vasoconstriction in the nonspastic seg-
ments in patients with Prinzmetal's variant angina was 
similar in character and magnitude to that observed in the 
control group and patients with coronary artery disease. Our 
results are in contrast to findings by Hoshio et al. (I), who 
reported that in their patients with variant angina, not only 
spastic coronary segments but also nons pas tic segments had 
a more prominent response to ergonovine (and nitrate) than 
the coronary arteries in their control patients. In their 
opinion, "the entire coronary tree rather than a localized 
segment may have increased basal coronary tone and sensi-
tivity to vasoconstrictive stimuli" (1). 
Studies in western versus Japanese patients. In our study, 
coronary vasodilation after isosorbide dinitrate was not 
significantly different in control patients, patients with vari-
ant angina and patients with coronary artery disease. This is 
also in contrast to observations by Hoshio et al. (I), who 
reported a generalized coronary vasomotion disorder in 
response to nitrate in patients with variant angina. Although 
marked dilation confined to the spastic segments had been 
previously reported (4) after the administration of nitrate, 
marked dilation of the nonspastic vessels has not been 
previously reported in typical variant angina. The extent of 
coronary artery dilation found by the Japanese group (I) in 
patients with variant angina is much larger than that reported 
in western patients (2-4), but the extent of coronary dilation 
in their nonvariant angina group is less than that observed by 
other authors (11-14). 
Several reasons may account for the different findings in 
our study compared with those of Hoshio et al. (1). 1) Ours 
was a prospective study, whereas Hoshio et al. (I) per-
formed a retrospective patient and angiographic analysis. 
Table 3. Coronary Artery Diameter of Proximal and Distal Segments on the Control Arteriogram and After Intracoronary Isosorbide 
Dinitrate in 63 Patients 
Proximal Segments Distal Segments 
Control Nitrate % Control Nitrate % 
(mm) (mm) Dilation (mm) (mm) Dilation 
Control group 2.75 ± 0.09 3.11 ± 0.10 13 ± 2 1.56 ± 0.07 1.76 ± 0.07 13 ± 3 
(n = 9) 
Variant angina 2.83 ± 0.14 3.13 ± 0.16 II ± 3 1.63 ± 0.07 1.86 ± 0.10 14 ± 4 
(n = 13) 
Coronary artery disease 2.76 ± 0.09 3.00 ± 0.09 8 ± 2 1.56 ± 0.05 1.78 ± 0.06 15 ± 2* 
(n = 41) 
*p < 0.05 versus proximal segments. 
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Figure 3. Coronary artery vasodilation (percent change in coronary 
diameter compared with control) of angiographically normal (non-
spastic segments in patients with variant angina) proximal and distal 
coronary segments in response to intracoronary isosorbide dinitrate. 
In the coronary artery disease (CAD) group, vasodilation of distal 
coronary segments was significantly larger than that of proximal 
segments. 
2) Different patient selection may have played a role 
because the patients in their study (1) appear to represent 
a selected group in whom diffuse rather than focal 
hyperreactivity is the mechanism of variant angina). 3) 
Ethnic differences could be postulated because studies 
(15,16) from Japan frequently report the presence of 
multivessel, mUltiple segment and diffuse coronary artery 
spasm, which is rather uncommon in western studies 07-
19). This, however, is an unlikely explanation because other 
Japanese studies 00,20) have confirmed the presence of 
local coronary hyperreactivity in variant angina. 4) It is 
also possible that some of the patients in the study of Hoshio 
et al. (1) had some degree of vasoconstriction during baseline 
coronary arteriography, which could have accounted for the 
smaller baseline diameter observed in that study. 5) Finally, 
different doses of ergonovine and nitrate and different nitrate 
preparations were used in different patients in the Japanese 
study (1). 
We did not obtain control angiograms after ergonovine in 
patients with variant angina and this may be a limitation of 
our study; however, this is justified on ethical grounds 
because these patients developed angina and ST segment 
changes that required prompt treatment. Nevertheless, in 
the study of Hoshio et al. 0), only the baseline angiogram 
was used as a control for both ergonovine and nitrate in 
every case. 
Conclusions. Our results confirm that local coronary hy-
perreactivity is the prevailing mechanism underlying coro-
nary artery spasm in variant angina. Epicardial coronary 
artery reactivity (normal coronary segments) is similar in 
patients with noncardiac chest pain, Prinzmetal's variant 
angina (nonspastic segments) and coronary artery disease. 
The data suggest that evaluation of basal coronary artery 
lACC Vol. 17, No.5 
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diameter is not useful for predicting the occurrence or 
location of coronary artery spasm. 
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